InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | Stueland Katherine | Director & CHIEF EXECUTIVE OFFICER | Sale | 2,172 | $65.19 | $142K | 93.2K | View ↗ | |
| 2026-04-29 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sale | 392 | $65.19 | $26K | 34.9K | View ↗ | |
| 2026-03-26 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sale | 8,818 | $63.17 | $557K | 34.6K | View ↗ | |
| 2026-03-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sale | 5,706 | $76.80 | $438K | 27.1K | View ↗ | |
| 2026-03-09 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sale | 1,280 | $86.75 | $111K | 21.8K | View ↗ |
No annual data found.
Alger Small Cap Growth Fund Q1 2026 Portfolio Update
Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings?
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
Three Best Genomics Stocks for Your Portfolio in 2026